In quality health care accountability and protection, further providing for definitions and providing for utilization management for stage four, advanced metastatic cancer drugs; and making a repeal.
Impact
The passage of HB 2427 will have significant implications for patients suffering from advanced metastatic cancer within Pennsylvania. This bill is anticipated to lead to more timely access to essential medications, potentially improving patient outcomes by ensuring they receive the appropriate treatment without unnecessary delays. The implementation of section 2157.1 means that insurance policies must be compliant with this new directive, leading to changes in how insurers manage drug therapies related to advanced cancer. This is expected to standardize treatment protocols and remove barriers that patients have traditionally faced when seeking coverage for necessary drugs.
Summary
House Bill 2427 is a legislative proposal in Pennsylvania aimed at enhancing healthcare accountability and access for patients dealing with stage four, advanced metastatic cancer. This bill specifically modifies the existing framework surrounding specific drug treatments for this serious condition by introducing a section that amends the Insurance Company Law of 1921. One of the main provisions included in this bill is the prohibition of insurance companies from requiring patients to try and fail on alternative treatments before accessing medications that are deemed medically necessary for their condition, provided these drugs are FDA-approved and supported by established medical literature.
Contention
Despite its potential benefits, HB 2427 may also encounter opposition from various stakeholders within the healthcare sector. Critics may argue that mandates on insurance coverage can lead to increased costs for insurers and, ultimately, consumers. Moreover, the repeal of the Fair Access to Cancer Treatment Law, which HB 2427 enacts, points to a broader debate about how best to ensure equitable access to cancer therapies while maintaining sustainable healthcare costs. There may be concerns about the legal and financial ramifications for insurance companies, which could affect the bill's support among certain legislative members and lobby groups.
Providing for behavioral health benefits for justice-involved children; and, in juvenile matters, further providing for definitions and for costs and expenses of care of child, providing for mandatory intake conference and screening in cases alleging delinquency and further providing for informal adjustment and for powers and duties.
In general provisions, further providing for definitions; in Commonwealth services, further providing for definitions; and, in emergency responder mental wellness and stress management, further providing for definitions.
In protection from abuse, further providing for definitions and for relief; and, in protection of victims of sexual violence or intimidation, further providing for definitions and for relief.
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)